Gail Stanley, MD, MPH

Stanley G, Chan B, Wuerstle S, Grun C, Kazmierczak B, Sun Y, Kortright K, Turner P, Koff J. Single Sequential Bacteriophage Therapy Decreases Pseudomonas Virulence More Than a Cocktail Approach. 2023, a1228-a1228. DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1228.

Harris Z, Sun Y, Joerns J, Clark B, Hu B, Korde A, Sharma L, Shin H, Manning E, Placek L, Unutmaz D, Stanley G, Chun H, Sauler M, Rajagopalan G, Zhang X, Kang M, Koff J. Epidermal Growth Factor Receptor Regulates Beclin-1 in Hyperoxia-Induced Lung Injury. 2023, a1256-a1256. DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1256.

Geyer J, Krupa K, Harris Z, Sun Y, Sharma L, Würstle S, Hu B, Stanley G, Rajagopalan G, Pellot E, Koff J, Robinson J. A Novel Zinc (II) Porphyrin Is Synergistic with PEV2 Bacteriophage against Pseudomonas aeruginosa Infections. Antibiotics 2023, 12: 735. PMID: 37107097, PMCID: PMC10135120, DOI: 10.3390/antibiotics12040735.

Sun Y, Hu B, Stanley G, Harris ZM, Gautam S, Homer R, Koff JL, Rajagopalan G. IFN-γ Is Protective in Cytokine Release Syndrome-associated Extrapulmonary Acute Lung Injury. American Journal Of Respiratory Cell And Molecular Biology 2023, 68: 75-89. PMID: 36125351, PMCID: PMC9817908, DOI: 10.1165/rcmb.2022-0117oc.

Winzig F, Gandhi S, Lee A, Würstle S, Stanley G, Capuano I, Neuringer I, Koff J, Turner P, Chan B. Inhaled Bacteriophage Therapy for Multi-Drug Resistant Achromobacter. The Yale Journal Of Biology And Medicine 2022, 95: 413-427. PMID: 36568830, PMCID: PMC9765334.

Murray T, Stanley G, Koff J. Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis. Clinics In Chest Medicine 2022, 43: 667-676. PMID: 36344073, DOI: 10.1016/j.ccm.2022.06.008.

Stanley G, Chan B, Wuerstle S, Grun C, Kazmierczak B, Sun Y, Kortright K, Turner P, Koff J. 539 Single sequential bacteriophage therapy decreases Pseudomonas virulence in cystic fibrosis more than a cocktail approach. Journal Of Cystic Fibrosis 2022, 21: s300. DOI: 10.1016/s1569-1993(22)01229-2.

Harris Z, Geyer J, Sun Y, Hu B, Wuerstle S, Stanley G, Rajagopalan G, Robinson J, Koff J. 563 Novel porphyrin targets biofilm, Pseudomonas aeruginosa, and Staphylococcus aureus. Journal Of Cystic Fibrosis 2022, 21: s313-s314. DOI: 10.1016/s1569-1993(22)01253-x.

Harris ZM, Sun Y, Joerns J, Clark B, Hu B, Korde A, Sharma L, Shin HJ, Manning EP, Placek L, Unutmaz D, Stanley G, Chun H, Sauler M, Rajagopalan G, Zhang X, Kang MJ, Koff JL. Epidermal Growth Factor Receptor Inhibition Is Protective in Hyperoxia-Induced Lung Injury. Oxidative Medicine And Cellular Longevity 2022, 2022: 9518592. PMID: 36193076, PMCID: PMC9526641, DOI: 10.1155/2022/9518592.

Harris Z, Sun Y, Joerns J, Clark B, Hu B, Korde A, Placek L, Unutmaz D, Stanley G, Chun H, Sauler M, Rajagopalan G, Zhang X, Kang M, Koff J. Epidermal Growth Factor Receptor (EGFR) Modulates Apoptosis in Hyperoxia-Induced Lung Injury. 2022, a2517-a2517. DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2517.

Stanley G, Chan B, Kortright K, Sun Y, Rajagopalan G, Harris Z, Turner P, Koff J. Lipopolysaccharide Targeted Bacteriophage Therapy Deceases Lung Inflammation in Cystic Fibrosis. 2022, a3452-a3452. DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a3452.

Stanley G, Modak M, Kortright K, Ott I, Sun Y, Korde A, Rajagopalan G, Chan B, Turner P, Koff J. 499: Bacteriophage therapy decreases cystic fibrosis lung inflammation. Journal Of Cystic Fibrosis 2021, 20: s235-s236. DOI: 10.1016/s1569-1993(21)01923-8.

Harris Z, Geyer J, Sun Y, Hu B, Stanley G, Rajagopalan G, Robinson J, Koff J. 514: Novel zinc porphyrin antibiotic shows activity against Pseudomonas in vivo. Journal Of Cystic Fibrosis 2021, 20: s243-s244. DOI: 10.1016/s1569-1993(21)01938-x.

Stanley G, Modak M, Chan B, Ott I, Sun Y, Harris Z, Kortright K, Turner P, Koff J. Bacteriophage Decrease Cystic Fibrosis Lung Inflammation. 2021, a1215-a1215. DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1215.

Harris Z, Korde A, Sun Y, Hu B, Rajagopalan G, Stanley G, Joerns J, Clark B, Koff J. Epidermal Growth Factor Receptor (EGFR) Modulates Apoptosis via ERK1/2 in Hyperoxia-Induced Lung Injury. 2021, a4367-a4367. DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4367.

Chan BK, Stanley G, Modak M, Koff JL, Turner PE. Bacteriophage therapy for infections in CF. Pediatric Pulmonology 2021, 56: s4-s9. PMID: 33434411, DOI: 10.1002/ppul.25190.

Stanley G, Chan B, Ott I, Mayo E, Harris Z, Sun Y, Hu B, Rajagopalan G, Turner P, Koff J. Bacteriophage Therapy Decreases Pseudomonas Aeruginosa Lung Inflammation. 2020, a2977-a2977. DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2977.

Harris Z, Chioccioli M, Joerns J, Clark B, Sun Y, Hu B, Stanley G, Rajagopalan G, Koff J. Novel Imaging of Hyperoxia-Induced Lung Injury Implicates Epidermal Growth Factor Receptor. 2020, a5551-a5551. DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a5551.

Rajagopalan G, Coutermarsh-Ott S, Sun Y, Hu B, Harris Z, Stanley G, Koff J. IL-17A and IFN-gamma Play Distinct Roles in Pulmonary and Extrapulmonary Acute Respiratory Distress Syndrome Induced by a Staphylococcal Superantigen. 2020, a7708-a7708. DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a7708.

Koff J, Chan B, Stanley G, Geer J, Grun C, Kazmerciak B, Turner P. Clinical Use of Inhaled Bacteriophages to Treat Multi-Drug Resistant Pseudomonas Aeruginosa. 2019, a7381-a7381. DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7381.